osinophilic esophagitis (EoE) is a chronic condition characterized by eosinophilicpredominant inflammation and esophageal dysfunction. 1 ,2 EoE represents a rapidly increasing cause of morbidity and a growing health problem.
Before the 1990s, clinicians infrequently recognized EoE. However, the publication of 3 seminal reports in the mid-1990s triggered a rapid increase in publications, facilitated the development of guidelines, 1, 2 and increased recognition of EoE. Whether this substantial increase in the medical literature translated into a more expedient diagnosis remains unknown. This study aimed to assess whether the symptomatic period preceding the diagnosis of EoE has decreased over time.
Methods
We conducted a retrospective cohort study using the University of North Carolina (UNC) EoE Clinicopathologic Database between 2000 and 2014. The UNC Institutional Review Board approved this study. This database contains data extracted from medical records for incident cases of EoE at UNC, diagnosed per consensus guidelines, with exclusion of proton pump inhibitor (PPI)-responsive esophageal eosinophilia.
1,2 The outcome variable was the length of symptoms preceding diagnosis and the independent variable was the year of diagnosis. Potential confounders included sex; race; age at diagnosis; dysphagia; history of food impaction; symptoms of abdominal pain, chest pain, and heartburn; and concomitant atopic diseases.
A linear regression model was constructed to assess the unadjusted relationship between the year of diagnosis and symptom length, then analysis of covariance assessed the relationship after adjusting for covariates. We calculated the predicted length of undiagnosed symptomatic periods for years corresponding with the publication of management guidelines: 2000 to 2006 (before first guidelines), 2007 to 2011 (after first guidelines), and after 2011 (after second guidelines). 1, 2 Additional adjusted models were constructed after stratifying by age: child (<18 y) or adult (!18 y). All analyses were performed using Stata 14.1 (College Station, TX).
Results
A total of 677 EoE cases were included in this study. At diagnosis, the mean age was 26 years (range, 1-82 y), 69% were male, 81% were white, and 40% had a history of an atopic condition. Dysphagia, heartburn, abdominal pain, and chest pain were reported in 71%, 39%, 22%, and 11% of patients, respectively. There were 194 patients (30%) with a history of food impaction preceding diagnosis. Adults (age, !18 y) comprised 56% of the cohort. Overall, the mean duration of symptoms before diagnosis was 7.4 AE 8.7 years.
The unadjusted association between length of symptoms and year of diagnosis as a continuous variable was significant and increased over time (P ¼ .03) ( Figure 1A ). This relationship attenuated substantially within a multivariable model (P ¼ .57) (Figure 1B Figure 1C) . A similar pattern for children was found in the corresponding years with predicted symptomatic periods of 2.8, 3.5, and 3.7 years, respectively (P ¼ .32) ( Figure 1D ).
Discussion
We hypothesized that the length of EoE-associated symptoms before diagnosis should decrease over time.
Instead, we found that symptom length preceding diagnosis did not statistically correlate with the year of diagnosis and has not decreased. These findings were true in both children and adults. The reason for this paradoxic finding is unknown and warrants additional study.
1,2 It remains unclear if these findings occurred because patients do not recognize their symptoms as a disease process, lack of referral to or unavailability of specialists, or under-recognition by providers.
Limitations included the analysis of data from a single and tertiary care center, which raises concern for referral bias and poor generalizability. For example, referral patients may have more severe and/or longstanding symptoms. However, the demographic features of our cohort are typical of a nonreferral population. Because EoE and PPI-responsive esophageal eosinophilia are similar in many aspects, the exclusion of PPI-responsive patients does not likely bias our results. [3] [4] [5] [6] [7] [8] It did diminish sample size and produced a less precise estimate. Also, differentiating EoE and PPIresponsive patients should prolong diagnosis by 6 to 8 weeks at most. 1 Strengths included the study size, inclusion of confounding covariates, and the homogenous sample.
In conclusion, the length of symptoms before EoE diagnosis has not decreased over time, but may be increasing. Increased efforts should be made to increase awareness of this disease. Future studies should assess these results in PPI-responsive patients. 
